# China NMPA Product Recall - Cerebrospinal fluid shunt tubes and accessories; lumbosacral-abdominal shunt tube assembly

Source: https://www.globalkeysolutions.net/records/china_product_recall/medtronic-shanghai-management-co-ltd/7a1496ad-e9e1-4bf0-aabc-c332e0866c31/
Source feed: China

> China NMPA product recall for Cerebrospinal fluid shunt tubes and accessories; lumbosacral-abdominal shunt tube assembly by Medtronic (Shanghai) Management Co., Ltd. published February 03, 2021. Recall level: Level 2 Recall. On February 3, 2021, Medtronic (Shanghai) Management Co., Ltd. initiated a voluntary Class II recall

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Medtronic (Shanghai) Management Co., Ltd. is voluntarily recalling cerebrospinal fluid shunts and accessories; lumbosacral-abdominal shunt assemblies.
- Company Name: Medtronic (Shanghai) Management Co., Ltd.
- Publication Date: 2021-02-03
- Product Name: Cerebrospinal fluid shunt tubes and accessories; lumbosacral-abdominal shunt tube assembly
- Recall Level: Level 2 Recall
- Recall Reason: The issue concerns Medtronic adjustable and fixed pressure shunt valves used for hydrocephalus management. The visibility of radiopaque dot markings may vary under X-rays for certain models and batches. This issue does not affect the performance or efficacy of the shunt valves, but it may limit the ability to confirm valve pressure settings and cerebrospinal fluid flow direction via X-ray.
- Discovering Company: Medtronic (Shanghai) Management Co., Ltd.
- Manufacturing Company: Medtronic (Shanghai) Management Co., Ltd.
- Summary: On February 3, 2021, Medtronic (Shanghai) Management Co., Ltd. initiated a voluntary Class II recall of specific cerebrospinal fluid shunt tubes, accessories, and lumbosacral-abdominal shunt assemblies. This action, reported under the National Medical Products Administration (NMPA) and the Shanghai Municipal Drug Administration, stemmed from a potential issue with the radiopaque dot markings on certain adjustable and fixed pressure shunt valves. The primary concern was the inconsistent visibility of these markings under X-ray, which could hinder medical professionals' ability to accurately confirm valve pressure settings and cerebrospinal fluid flow direction. While the company stated that this variation does not compromise the overall performance or efficacy of the shunt valves, the recall was deemed necessary to address the diagnostic limitation. Medtronic took self-corrective measures by informing customers and recalling the affected products, ensuring compliance with regulatory standards and patient safety regarding diagnostic clarity.

Company: https://www.globalkeysolutions.net/companies/medtronic-shanghai-management-co-ltd/e5ba243d-a47a-4442-84d4-1e11f92f75e2/